In addition to imaging, pathology plays a crucial role as a diagnostic tool, with markers like Melan A and HMB-45, along with the NRAS mutation, being the predominant markers identified in primary central nervous system melanoma. This evidence concerns the gene MLANA and primary melanoma of the central nervous system.